SEC Form 4 · accession 0001415889-18-001538
Medite Cancer Diagnostics, Inc. · MDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John H Abeles
Director
Period of report
Oct 11, 2018
Accepted (ET)
Oct 23, 2018 · 2:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075439
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 13, 2018 | J | 40,000 | — | A | 1,300,185 | I | Northlea Partners, Ltd. |
| Common Stock | Oct 11, 2018 | P | 266,667 | $0.075 | A | 1,566,852 | I | Northlea Partners, Ltd. |
| Common Stock | holding | — | — | — | 116,350 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F140,000 shares were issued to Northlea Partners, Ltd. for accrued interest on a debt.